MALAT1 and osteosarcoma: Consistent with these studies, high-dose 17β-estradiol (E2) treatment markedly downregulated MALAT1-mediated osteosarcoma cell proliferation, migration, invasion, and metastasis by upregulating miR-9 in E2-dose-dependent and ER-independent manners.